Giuseppa Maltese

890 total citations
25 papers, 394 citations indexed

About

Giuseppa Maltese is a scholar working on Reproductive Medicine, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, Giuseppa Maltese has authored 25 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Reproductive Medicine, 12 papers in Oncology and 12 papers in Obstetrics and Gynecology. Recurrent topics in Giuseppa Maltese's work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (12 papers) and PARP inhibition in cancer therapy (6 papers). Giuseppa Maltese is often cited by papers focused on Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (12 papers) and PARP inhibition in cancer therapy (6 papers). Giuseppa Maltese collaborates with scholars based in Italy, United States and India. Giuseppa Maltese's co-authors include Domenica Lorusso, Francesco Raspagliesi, Giorgio Bogani, Ilaria Sabatucci, Antonino Ditto, Giovanni Scambia, Valentina Chiappa, Fabio Martinelli, Giovanni Fucà and Cono Scaffa and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of Surgical Oncology.

In The Last Decade

Giuseppa Maltese

21 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giuseppa Maltese Italy	11	215	203	115	85	84	25	394
Lingfang Xia China	15	170 0.8×	205 1.0×	172 1.5×	56 0.7×	93 1.1×	35	485
Charles‐André Philip France	12	199 0.9×	172 0.8×	114 1.0×	39 0.5×	34 0.4×	34	350
Eman Abdulfatah United States	10	117 0.5×	150 0.7×	45 0.4×	82 1.0×	53 0.6×	31	306
C. Madroñal Spain	4	446 2.1×	254 1.3×	153 1.3×	88 1.0×	176 2.1×	11	533
David Shimizu United States	11	97 0.5×	162 0.8×	135 1.2×	123 1.4×	133 1.6×	26	450
Gonzalo Giornelli Argentina	5	241 1.1×	254 1.3×	110 1.0×	36 0.4×	30 0.4×	8	421
Maria M. Rubinstein United States	10	107 0.5×	124 0.6×	105 0.9×	44 0.5×	34 0.4×	26	304
Toshinori Kawagoe Japan	12	153 0.7×	221 1.1×	64 0.6×	25 0.3×	53 0.6×	35	375
Eunice H. Rhee United States	5	146 0.7×	105 0.5×	133 1.2×	85 1.0×	127 1.5×	5	403
Jennifer McLachlan United Kingdom	10	116 0.5×	61 0.3×	113 1.0×	45 0.5×	58 0.7×	21	280

Countries citing papers authored by Giuseppa Maltese

Since Specialization

Citations

This map shows the geographic impact of Giuseppa Maltese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppa Maltese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppa Maltese more than expected).

Fields of papers citing papers by Giuseppa Maltese

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppa Maltese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppa Maltese. The network helps show where Giuseppa Maltese may publish in the future.

Co-authorship network of co-authors of Giuseppa Maltese

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppa Maltese. A scholar is included among the top collaborators of Giuseppa Maltese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppa Maltese. Giuseppa Maltese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lorusso, Domenica, Giuseppa Maltese, Ilaria Sabatucci, et al.. (2020). Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile. Targeted Oncology. 16(1). 59–68. 12 indexed citations

Maltese, Giuseppa, et al.. (2019). Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective study. International Journal of Gynecological Cancer. 29(2). 272–276. 4 indexed citations

Lorusso, Domenica, Gabriella Ferrandina, Nicoletta Colombo, et al.. (2019). Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial. Gynecologic Oncology. 155(3). 406–412. 67 indexed citations

Bogani, Giorgio, Laura Matteucci, Stefano Tamberi, et al.. (2019). RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 237. 93–99. 15 indexed citations

Sabatucci, Ilaria, et al.. (2018). Rucaparib: a new treatment option for ovarian cancer. Expert Opinion on Pharmacotherapy. 19(7). 765–771. 6 indexed citations

Lorusso, Domenica, et al.. (2018). Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy. Drug Design Development and Therapy. Volume 12. 1501–1509. 27 indexed citations

Lorusso, Domenica, Fabio Martinelli, Giuseppa Maltese, et al.. (2018). Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach?. Oncology. 95(4). 239–245. 2 indexed citations

Raspagliesi, Francesco, Giorgio Bogani, Laura Matteucci, et al.. (2018). Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC–IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study. International Journal of Gynecological Cancer. 28(9). 1706–1713. 4 indexed citations

Vincenzi, Bruno, Giuseppe Badalamenti, Grazia Armento, et al.. (2018). Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin. Oncology. 95(1). 1–7. 9 indexed citations

10.

Bogani, Giorgio, Giuseppa Maltese, Federica Morano, et al.. (2017). Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: a predictors- and nomogram-based analyses. Annals of Oncology. 28. vi70–vi70.

11.

Maltese, Giuseppa, Caterina Fontanella, Cono Scaffa, et al.. (2017). Atypical Uterine Smooth Muscle Tumors: A Retrospective Evaluation of Clinical and Pathologic Features. Oncology. 94(1). 1–6. 8 indexed citations

12.

Raspagliesi, Francesco, Giorgio Bogani, Antonino Ditto, et al.. (2017). Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers. Annals of Surgical Oncology. 24(11). 3396–3405. 11 indexed citations

13.

Fontanella, Caterina, Amelia Barcellini, Maria Giuseppa Vitale, et al.. (2017). Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer?. Annals of Oncology. 28. vi70–vi70. 1 indexed citations

14.

Bogani, Giorgio, Laura Matteucci, Stefano Tamberi, et al.. (2017). The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer. International Journal of Gynecological Cancer. 27(9). 1856–1862. 43 indexed citations

15.

Raspagliesi, Francesco, Giuseppa Maltese, Giorgio Bogani, et al.. (2016). Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: A retrospective MITO group study. Gynecologic Oncology. 144(1). 90–95. 60 indexed citations

16.

Bogani, Giorgio, Ilaria Sabatucci, Giuseppa Maltese, et al.. (2016). Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology. 208. 41–45. 13 indexed citations

17.

Bogani, Giorgio, Giovanni Fucà, Giuseppa Maltese, et al.. (2016). Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis. Gynecologic Oncology. 143(2). 443–447. 41 indexed citations

18.

Lorusso, Domenica, Giovanni Scambia, Sandro Pignata, et al.. (2015). Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial. Annals of Oncology. 27(3). 487–493. 45 indexed citations

19.

Badalamenti, Giuseppe, Giuseppe Bronte, Salvatore Provenzano, et al.. (2010). 69 PRIMARY PROPHYLAXIS OF FEBRILE NEUTROPENIA BY LENOGRASTIM IN SARCOMA, BREAST AND LUNG CANCER PATIENTS TREATED WITH CHEMOTHERAPY. Cancer Treatment Reviews. 36. S115–S115.

20.

Gafà, Lorenzo, et al.. (1992). [Analysis of the quality of death certificates for neoplasms in the province of Ragusa].. PubMed. 14(51). 30–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact